| Chamomile: A herbal medicine of the past with a bright future JK Srivastava, E Shankar, S Gupta Molecular medicine reports 3 (6), 895-901, 2010 | 1139 | 2010 |
| Plant flavone apigenin: an emerging anticancer agent E Shankar, A Goel, K Gupta, S Gupta Current pharmacology reports 3, 423-446, 2017 | 179 | 2017 |
| Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges E Shankar, R Kanwal, M Candamo, S Gupta Seminars in cancer biology 40, 82-99, 2016 | 164 | 2016 |
| Suppression of NF-κB and NF-κB-regulated gene expression by apigenin through IκBα and IKK pathway in TRAMP mice S Shukla, E Shankar, P Fu, GT MacLennan, S Gupta Plos one 10 (9), e0138710, 2015 | 107 | 2015 |
| Apigenin blocks IKKα activation and suppresses prostate cancer progression S Shukla, R Kanwal, E Shankar, M Datt, MR Chance, P Fu, ... Oncotarget 6 (31), 31216, 2015 | 98 | 2015 |
| Dopaminergic regulation of glucose‐induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro E Shankar, KT Santhosh, CS Paulose IUBMB life 58 (3), 157-163, 2006 | 86 | 2006 |
| High‐fat diet increases NF‐κB signaling in the prostate of reporter mice EV Vykhovanets, E Shankar, OV Vykhovanets, S Shukla, S Gupta The Prostate 71 (2), 147-156, 2011 | 81 | 2011 |
| Androgen receptor‐related diseases: what do we know? GC Shukla, AR Plaga, E Shankar, S Gupta Andrology 4 (3), 366-381, 2016 | 79 | 2016 |
| High‐fat diet activates pro‐inflammatory response in the prostate through association of Stat‐3 and NF‐κB E Shankar, EV Vykhovanets, OV Vykhovanets, GT MacLennan, R Singh, ... The Prostate 72 (3), 233-243, 2012 | 75 | 2012 |
| Downregulation of Bid is associated with PKCɛ-mediated TRAIL resistance U Sivaprasad, E Shankar, A Basu Cell Death & Differentiation 14 (4), 851-860, 2007 | 74 | 2007 |
| Betulinic acid-mediated apoptosis in human prostate cancer cells involves p53 and nuclear factor-kappa B (NF-κB) pathways E Shankar, A Zhang, D Franco, S Gupta Molecules 22 (2), 264, 2017 | 69 | 2017 |
| Green tea–induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase‐3 suppresses prostate cancer progression through histone‐modifying enzymes G Deb, E Shankar, VS Thakur, LE Ponsky, DR Bodner, P Fu, S Gupta Molecular carcinogenesis 58 (7), 1194-1207, 2019 | 66 | 2019 |
| Oxidative stress and antioxidant status in high-risk prostate cancer subjects S Shukla, JK Srivastava, E Shankar, R Kanwal, A Nawab, H Sharma, ... Diagnostics 10 (3), 126, 2020 | 62 | 2020 |
| Simultaneous detection of oral pathogens in subgingival plaque and prostatic fluid of men with periodontal and prostatic diseases J Estemalik, C Demko, NF Bissada, N Joshi, D Bodner, E Shankar, ... Journal of periodontology 88 (9), 823-829, 2017 | 61 | 2017 |
| Inflammatory signaling involved in high-fat diet induced prostate diseases E Shankar, N Bhaskaran, GT MacLennan, G Liu, F Daneshgari, S Gupta Journal of urology and research 2 (1), 2015 | 61 | 2015 |
| Protein kinase Cɛ confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53 E Shankar, U Sivaprasad, A Basu Oncogene 27 (28), 3957-3966, 2008 | 56 | 2008 |
| Protein kinase C-ε protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation D Lu, U Sivaprasad, J Huang, E Shankar, S Morrow, A Basu Apoptosis 12, 1893-1900, 2007 | 48 | 2007 |
| MiR-644a disrupts oncogenic transformation and warburg effect by direct modulation of multiple genes of tumor-promoting pathways JS Ebron, E Shankar, J Singh, K Sikand, CM Weyman, S Gupta, ... Cancer Research 79 (8), 1844-1856, 2019 | 45 | 2019 |
| Statin use in prostate cancer: an update MA Babcook, A Joshi, JA Montellano, E Shankar, S Gupta Nutrition and metabolic insights 9, NMI. S38362, 2016 | 45 | 2016 |
| Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells K Song, E Shankar, J Yang, KL Bane, R Wahdan-Alaswad, D Danielpour PloS one 8 (5), e61896, 2013 | 45 | 2013 |
